Articles Tagged: FTC


FTC Cracking Down on Drug Manufacturers' "Pay-for-Delay" Practices

On March 30th, the Federal Trade Commission filed a lawsuit against drug manufacturer Endo Pharmaceuticals, alleging that Endo is paying generic drug manufacturers in order to delay the release of lower cost generic versions of their drugs, Opana ER and Lidoderm.

Generic drugs come to market when the patents on name brand drugs expire.